Compile Data Set for Download or QSAR
Report error Found 54 of ec50 for UniProtKB: P18089
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50019057((+/-)4-Fluoro-5-(1-hydroxy-2-methylamino-ethyl)-be...)
Affinity DataEC50:  100nMAssay Description:Agonistic potency at alpha 2-Adrenergic receptor for inhibition of 10 uM forskolin-elicited stimulation of adenylate cyclase in human platelet membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2012
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476638(CHEMBL75389)
Affinity DataEC50:  166nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50029050(4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2...)
Affinity DataEC50:  300nMAssay Description:Agonistic potency at alpha 2-Adrenergic receptor for inhibition of 10 uM forskolin-elicited stimulation of adenylate cyclase in human platelet membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2012
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50270853(CHEMBL4128374)
Affinity DataEC50:  500nMAssay Description:Activity at alpha2 adrenergic receptor in human brain prefrontal cortex membranes assessed as effect on UK14304-induced [35S]GTPgammaS binding by mea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50270852(CHEMBL4125770)
Affinity DataEC50:  800nMAssay Description:Activity at alpha2 adrenergic receptor in human brain prefrontal cortex membranes assessed as effect on UK14304-induced [35S]GTPgammaS binding by mea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50020819(CHEMBL543126 | N-[2-Hydroxy-5-(2-methylamino-ethyl...)
Affinity DataEC50:  1.20E+3nMAssay Description:Effective concentration (EC50) against alpha-2-adrenoceptor in the guinea pig atriumMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2012
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50270781(CHEMBL4129213)
Affinity DataEC50:  1.50E+3nMAssay Description:Activity at alpha2 adrenergic receptor in human brain prefrontal cortex membranes assessed as effect on UK14304-induced [35S]GTPgammaS binding by mea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50270855(CHEMBL4129427)
Affinity DataEC50:  1.70E+3nMAssay Description:Activity at alpha2 adrenergic receptor in human brain prefrontal cortex membranes assessed as effect on UK14304-induced [35S]GTPgammaS binding by mea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50479675(CHEMBL473567)
Affinity DataEC50:  1.90E+3nMAssay Description:Agonist activity at alpha2 adrenoceptor in human cortical membrane after 2 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50070076(CHEMBL3407828)
Affinity DataEC50:  2.71E+3nMAssay Description:Antagonist activity at human alpha-2 adrenergic receptor in brain prefrontal cortex membrane assessed as inhibition of UK14304-induced [35S]-GTPgamma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2016
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476631(CHEMBL230861)
Affinity DataEC50:  2.76E+3nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50070101(CHEMBL3407840)
Affinity DataEC50:  3.57E+3nMAssay Description:Antagonist activity at human alpha-2 adrenergic receptor in brain prefrontal cortex membrane assessed as inhibition of UK14304-induced [35S]-GTPgamma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2016
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562358(CHEMBL4787567)
Affinity DataEC50:  4.14E+3nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50070100(CHEMBL3408018)
Affinity DataEC50:  4.23E+3nMAssay Description:Antagonist activity at human alpha-2 adrenergic receptor in brain prefrontal cortex membrane assessed as inhibition of UK14304-induced [35S]-GTPgamma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2016
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476630(CHEMBL242102)
Affinity DataEC50:  4.38E+3nMAssay Description:Antagonist activity at human brain adrenergic alpha-2 receptor assessed as UK-14304-stimulated [35S]GTPgammaS binding at 10 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50019059(3-Fluoro-4-(1-hydroxy-2-methylamino-ethyl)-benzene...)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonistic potency at alpha 2-Adrenergic receptor for inhibition of 10 uM forskolin-elicited stimulation of adenylate cyclase in human platelet membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2012
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50270854(CHEMBL4127933)
Affinity DataEC50:  6.60E+3nMAssay Description:Activity at alpha2 adrenergic receptor in human brain prefrontal cortex membranes assessed as effect on UK14304-induced [35S]GTPgammaS binding by mea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50070099(CHEMBL3408019)
Affinity DataEC50:  6.71E+3nMAssay Description:Antagonist activity at human alpha-2 adrenergic receptor in brain prefrontal cortex membrane assessed as inhibition of UK14304-induced [35S]-GTPgamma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2016
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562357(CHEMBL4795780)
Affinity DataEC50:  1.02E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50270851(CHEMBL4127137)
Affinity DataEC50:  1.07E+4nMAssay Description:Activity at alpha2 adrenergic receptor in human brain prefrontal cortex membranes assessed as effect on UK14304-induced [35S]GTPgammaS binding by mea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM34572(UK 14,304 | SMR000058355 | CHEMBL844 | cid_2435 | ...)
Affinity DataEC50:  1.14E+4nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM34572(UK 14,304 | SMR000058355 | CHEMBL844 | cid_2435 | ...)
Affinity DataEC50:  1.14E+4nMAssay Description:Agonist activity at alpha2 adrenoceptor in human cortical membrane after 2 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50270780(CHEMBL4125903)
Affinity DataEC50:  1.14E+4nMAssay Description:Activity at alpha2 adrenergic receptor in human brain prefrontal cortex membranes assessed as effect on UK14304-induced [35S]GTPgammaS binding by mea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562354(CHEMBL4763113)
Affinity DataEC50:  1.16E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476636(CHEMBL1204388 | 4-Guanidinoaniline Dihydrochloride...)
Affinity DataEC50:  1.60E+4nMAssay Description:Antagonist activity at human brain adrenergic alpha-2 receptor assessed as UK-14304-stimulated [35S]GTPgammaS binding at 10 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50479674(CHEMBL482359)
Affinity DataEC50:  1.62E+4nMAssay Description:Agonist activity at alpha2 adrenoceptor in human cortical membrane after 2 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562353(CHEMBL3216452)
Affinity DataEC50:  1.80E+4nMAssay Description:Agonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562353(CHEMBL3216452)
Affinity DataEC50:  2.02E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562355(CHEMBL4755913)
Affinity DataEC50:  3.00E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476635(CHEMBL230644)
Affinity DataEC50:  3.04E+4nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562360(CHEMBL4745647)
Affinity DataEC50:  3.08E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50070098(CHEMBL3408028)
Affinity DataEC50:  3.70E+4nMAssay Description:Antagonist activity at human alpha-2 adrenergic receptor in brain prefrontal cortex membrane assessed as inhibition of UK14304-induced [35S]-GTPgamma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2016
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50479677(CHEMBL482200)
Affinity DataEC50:  3.87E+4nMAssay Description:Agonist activity at alpha2 adrenoceptor in human cortical membrane after 2 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562359(CHEMBL4799288)
Affinity DataEC50:  3.99E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476646(CHEMBL242839)
Affinity DataEC50:  4.22E+4nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50223870(CHEMBL9441)
Affinity DataEC50:  4.53E+4nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562355(CHEMBL4755913)
Affinity DataEC50:  4.60E+4nMAssay Description:Agonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562356(CHEMBL4798553)
Affinity DataEC50:  5.23E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50213214(CHEMBL42139)
Affinity DataEC50:  5.64E+4nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50479679(CHEMBL506313)
Affinity DataEC50:  5.93E+4nMAssay Description:Agonist activity at alpha2 adrenoceptor in human cortical membrane after 2 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50070081(CHEMBL3408032)
Affinity DataEC50:  6.03E+4nMAssay Description:Antagonist activity at human alpha-2 adrenergic receptor in brain prefrontal cortex membrane assessed as inhibition of UK14304-induced [35S]-GTPgamma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2016
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50479673(CHEMBL467525)
Affinity DataEC50:  6.14E+4nMAssay Description:Agonist activity at alpha2 adrenoceptor in human cortical membrane after 2 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50479676(CHEMBL509581)
Affinity DataEC50:  8.23E+4nMAssay Description:Agonist activity at alpha2 adrenoceptor in human cortical membrane after 2 hrs by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50019492(RX821002 | CHEMBL10332 | 2-(2-methoxy-2,3-dihydrob...)
Affinity DataEC50:  8.72E+4nMAssay Description:Antagonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as inhibition of UK14304-induced stimulation of [35S]GTPgammaS bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476629(CHEMBL244986 | 4,4''-Di(2-Imidazolidinylimino)Diph...)
Affinity DataEC50:  1.20E+5nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476639(CHEMBL243061)
Affinity DataEC50:  1.41E+5nMAssay Description:Antagonist activity at human brain adrenergic alpha-2 receptor assessed as UK-14304-stimulated [35S]GTPgammaS binding at 10 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562356(CHEMBL4798553)
Affinity DataEC50:  1.94E+5nMAssay Description:Agonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation spe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50562356(CHEMBL4798553)
Affinity DataEC50:  2.52E+5nMAssay Description:Agonist activity at adrenergic alpha 2 receptor in human brain membrane assessed as stimulation of [35S]GTPgammaS binding in presence of adrenergic a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476634(CHEMBL244987 | 4,4''-Di(2-Imidazolidinylimino)Diph...)
Affinity DataEC50:  3.32E+5nMAssay Description:Agonist activity at human brain adrenergic alpha2 receptor by [35S]GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetAlpha-2A/Alpha-2B/Alpha-2C adrenergic receptor(Human)
National Institute of Diabetes

Curated by ChEMBL
LigandPNGBDBM50476632(CHEMBL390246)
Affinity DataEC50:  3.55E+5nMAssay Description:Antagonist activity at human brain adrenergic alpha-2 receptor assessed as UK-14304-stimulated [35S]GTPgammaS binding at 10 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 54 total ) | Next | Last >>
Jump to: